Bavarian Nordic, Acambis Settle Smallpox Fight
Under the agreement, Denmark-based Bavarian Nordic will grant a license to some Modified Vaccina Ankara-based patents in exchange for an “undisclosed upfront payment” from Acambis.
U.K.-based Acambis will also make royalty and milestone payments if it develops or commercializes certain MVA products in the future, the companies said. Other terms of the agreement are confidential.
To view the full article, register now.